NEG (n = 158) % (95% CI) | CIN1 (n = 79) % (95% CI) | CIN2 (n = 26) % (95% CI) | CIN3 (n = 50) % (95% CI) | CC (n = 3) % (95% CI) | |
---|---|---|---|---|---|
HPV16/18+ | 72.2 (64.6–78.6) | 68.4 (57.1–77.8) | 65.4 (44.3–81.8) | 60.0 (45.5–72.9) | 100 |
ASCUS+ | 30.4 (23.6–38.1) | 51.9 (40.7–62.9) | 61.5 (40.7–78.9) | 58.0 (43.6–71.2) | 0 |
LSIL+ | 25.9 (19.7–33.4) | 41.8 (31.2–53.1) | 61.5 (40.7–78.9) | 50.0 (36.0–64.0) | 0 |
HSIL+ | 3.2 (1.3–7.4) | 6.3 (2.6–14.6) | 19.2 (7.7–40.4) | 34.0 (21.9–48.6) | 0 |
S5 at 3.7 cutoff | 27.2 (20.8–34.8) | 26.6 (17.9–37.6) | 50.0 (30.5–69.5) | 66.0 (51.4–78.1) | 100 |
S5 at 0.8 cutoff | 57.6 (49.7–65.4) | 64.6 (53.2–74.5) | 73.1 (51.7–87.3) | 92.0 (79.9–97.1) | 100 |